1. Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany;
2. Department of Chemistry and Biochemistry, Gene Center, Ludwig-Maximilians Universität, Munich, Germany;
3. Institut für Chemie und Biochemie, Freie Universität, Berlin, Germany;
4. Pepscan Therapeutics BV, Lelystad, The Netherlands;
5. Sidec AB, Kista, Sweden; and
6. Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland